Investment Rating - The report does not explicitly provide an investment rating for the special medical purpose formula food industry in China Core Insights - The special medical purpose formula food (referred to as "special medical food") is designed to meet the specific nutritional needs of individuals with restricted diets, digestive absorption disorders, metabolic disorders, or specific disease states. These products must be consumed under the guidance of a physician or clinical nutritionist [2][10] - The market for special medical food in China has been rapidly growing since its classification as food rather than a drug in 2015, with a significant increase in registered products and a more regulated policy environment [3][15] - The report highlights a severe challenge in clinical nutrition support, with approximately 65% of hospitalized patients needing nutritional support, yet 70% of these patients do not receive effective support [3] Summary by Sections Industry Overview - The special medical food market in China is expected to grow significantly, driven by increasing clinical demand and expanding sales channels. The market size increased from 4.43 billion yuan in 2019 to 18.58 billion yuan in 2023, with a compound annual growth rate (CAGR) of 43.1%. It is projected to reach 47.03 billion yuan by 2028, with a CAGR of 20.4% [15][16] Definition and Classification - Special medical food is categorized into three types: full nutritional formula food, non-full nutritional formula food, and specific full nutritional formula food. The latter is designed to meet the nutritional needs of specific diseases or medical conditions [9][10] Policy Environment - The regulatory environment for special medical food has become increasingly stringent, with clear guidelines on clinical trial quality management and registration processes, promoting healthy industry development [2][3] Market Size - The market for special medical food is expected to continue expanding due to increased awareness and demand for clinical nutrition, with a significant gap in market penetration due to low public awareness and standardization issues [15][16] Industry Chain Analysis - The industry chain includes raw material suppliers, production manufacturers, and distribution channels. The report emphasizes the need for a complete ecosystem connecting all these segments [23][24] Competitive Landscape - As of the third quarter of 2024, 58 companies have registered special medical food products in China, with domestic companies significantly outnumbering foreign ones. However, domestic products tend to be more homogeneous, indicating a potential for diversification to enhance competitiveness [42][45]
2024年中国特殊医学用途配方食品行业概览:创新引领,构建健康康复新生态
Tou Bao Yan Jiu Yuan·2025-03-13 12:05